Express Scripts Holding Downgraded by Jefferson Research to Hold (ESRX)
Express Scripts Holding (NASDAQ:ESRX) was downgraded by research analysts at Jefferson Research from a “buy” rating to a “hold” rating in a report released on Friday, Analyst Ratings Network reports.
Other equities research analysts have also recently issued reports about the stock. Analysts at Goldman Sachs Group Inc. raised their price target on shares of Express Scripts Holding from $75.00 to $77.00 in a research note to investors on Tuesday, December 17th. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Express Scripts Holding in a research note to investors on Friday, December 13th. They now have a $70.00 price target on the stock. Finally, analysts at Morgan Stanley reiterated a “positive” rating on shares of Express Scripts Holding in a research note to investors on Friday, December 13th. They now have a $70.00 price target on the stock. Seven research analysts have rated the stock with a hold rating and nineteen have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $71.10.
Shares of Express Scripts Holding (NASDAQ:ESRX) opened at 69.955 on Friday. Express Scripts Holding has a 52-week low of $53.05 and a 52-week high of $70.79. The stock’s 50-day moving average is $67.50 and its 200-day moving average is $64.79. The company has a market cap of $56.370 billion and a P/E ratio of 31.45.
Express Scripts Holding (NASDAQ:ESRX) last released its earnings data on Friday, October 25th. The company reported $1.08 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.08. The company had revenue of $25.92 billion for the quarter, compared to the consensus estimate of $25.01 billion. During the same quarter last year, the company posted $1.02 earnings per share. Express Scripts Holding’s revenue was down 3.2% compared to the same quarter last year.
In other Express Scripts Holding news, Director Nicholas Lahowchic sold 12,694 shares of the company’s stock in a transaction that occurred on Thursday, December 26th. The shares were sold at an average price of $70.00, for a total value of $888,580.00. Following the transaction, the director now directly owns 24,903 shares of the company’s stock, valued at approximately $1,743,210. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Express Scripts, Inc is a pharmacy benefit management (NASDAQ:ESRX) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.